Diversity of HLA Class I and Class II blocks and conserved extended haplotypes in Lacandon Mayans

被引:0
|
作者
Rodrigo Barquera
Joaquin Zuniga
José Flores-Rivera
Teresa Corona
Bridget S. Penman
Diana Iraíz Hernández-Zaragoza
Manuel Soler
Letisia Jonapá-Gómez
Kalyan C. Mallempati
Petra Yescas
Adriana Ochoa-Morales
Konstantinos Barsakis
José Artemio Aguilar-Vázquez
Maricela García-Lechuga
Michael Mindrinos
María Yunis
Luis Jiménez-Alvarez
Lourdes Mena-Hernández
Esteban Ortega
Alfredo Cruz-Lagunas
Víctor Hugo Tovar-Méndez
Julio Granados
Marcelo Fernández-Viña
Edmond Yunis
机构
[1] Department of Archaeogenetics,
[2] Max Planck Institute for the Science of Human History (MPI-SHH),undefined
[3] Laboratory of Molecular Genetics,undefined
[4] Escuela Nacional de Antropología e Historia (ENAH),undefined
[5] Department of Immunology,undefined
[6] Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER),undefined
[7] Tecnologico de Monterrey,undefined
[8] Escuela de Medicina y Ciencias de la Salud,undefined
[9] Clinical Laboratory of Neurodegenerative Diseases,undefined
[10] Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”,undefined
[11] University of Warwick,undefined
[12] School of Life Sciences,undefined
[13] Immunogenetics Unit,undefined
[14] Técnicas Genéticas Aplicadas a la Clínica (TGAC),undefined
[15] Department of Transplantation,undefined
[16] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMSZ),undefined
[17] Public Health State Laboratory for Chiapas,undefined
[18] Tuxtla Gutierrez,undefined
[19] Histocompatibility,undefined
[20] Immunogenetics and Disease Profiling Laboratory,undefined
[21] Stanford Blood Center,undefined
[22] Biology Department,undefined
[23] University of Crete,undefined
[24] Department of Neurogenetics and Molecular Biology,undefined
[25] Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”,undefined
[26] Department of Pathology,undefined
[27] Clinical Analysis Laboratory,undefined
[28] Unidad Médica Familiar (UMF) No. 23,undefined
[29] Instituto Mexicano del Seguro Social (IMSS),undefined
[30] Stanford Genome Technology Center,undefined
[31] Department of Cancer Immunology and Virology,undefined
[32] Dana Farber Cancer Institute,undefined
[33] Harvard Medical School,undefined
[34] The William Harvey Research Institute,undefined
[35] Barts and London School of Medicine,undefined
[36] Queen Mary University of London,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Here we studied HLA blocks and haplotypes in a group of 218 Lacandon Maya Native American using a high-resolution next generation sequencing (NGS) method. We assessed the genetic diversity of HLA class I and class II in this population, and determined the most probable ancestry of Lacandon Maya HLA class I and class II haplotypes. Importantly, this Native American group showed a high degree of both HLA homozygosity and linkage disequilibrium across the HLA region and also lower class II HLA allelic diversity than most previously reported populations (including other Native American groups). Distinctive alleles present in the Lacandon population include HLA-A*24:14 and HLA-B*40:08. Furthermore, in Lacandons we observed a high frequency of haplotypes containing the allele HLA-DRB1*04:11, a relatively frequent allele in comparison with other neighboring indigenous groups. The specific demographic history of the Lacandon population including inbreeding, as well as pathogen selection, may have elevated the frequencies of a small number of HLA class II alleles and DNA blocks. To assess the possible role of different selective pressures in determining Native American HLA diversity, we evaluated the relationship between genetic diversity at HLA-A, HLA-B and HLA-DRB1 and pathogen richness for a global dataset and for Native American populations alone. In keeping with previous studies of such relationships we included distance from Africa as a covariate. After correction for multiple comparisons we did not find any significant relationship between pathogen diversity and HLA genetic diversity (as measured by polymorphism information content) in either our global dataset or the Native American subset of the dataset. We found the expected negative relationship between genetic diversity and distance from Africa in the global dataset, but no relationship between HLA genetic diversity and distance from Africa when Native American populations were considered alone.
引用
收藏
相关论文
共 50 条
  • [41] NON-CODING CLASS I SEQUENCES CONTAIN POLYMORPHISMS THAT ARE SPECIFIC FOR CONSERVED EXTENDED/ANCESTRAL HAPLOTYPES.
    Sayer, David C.
    Hogan, Hayley S.
    Goodridge, Damian M.
    Castley, Alison
    Smith, Linda K.
    HUMAN IMMUNOLOGY, 2010, 71 : S79 - S79
  • [42] HLA class I haplotypes in multiplex families with type I psoriasis.
    Henseler, T
    Lenk, W
    Jenisch, S
    Westphal, E
    Nair, RP
    Elder, JT
    Voorhees, JJ
    Christophers, E
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 778 - 778
  • [43] Diversity of HLA class I and class II alleles in Iran populations: Systematic review and Meta-Analaysis
    Abedini, Fateme
    Rahmanian, Narges
    Heidari, Zahra
    Feizi, Awat
    Sherkat, Roya
    Rezaei, Marzieh
    TRANSPLANT IMMUNOLOGY, 2021, 69
  • [44] HLA class II haplotypes in Mexican systemic lupus erythematosus patients
    Cortes, LM
    Baltazar, LM
    Lopez-Cardona, MG
    Olivares, N
    Ramos, C
    Salazar, M
    Sandoval, L
    Lorenz, MGO
    Chakraborty, R
    Paterson, AD
    Rivas, F
    HUMAN IMMUNOLOGY, 2004, 65 (12) : 1469 - 1476
  • [45] Visualizing HLA class II risk Haplotypes in human SLE.
    Graham, RR
    Ortmann, WA
    Langefeld, CD
    Jawaheer, D
    Nair, RP
    Elder, JT
    Moser, KL
    Gaffney, PM
    Bugawan, TL
    Erlich, PA
    Rich, SS
    Gregersen, PK
    Behrens, TW
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S392 - S393
  • [46] Association of HLA class II haplotypes response to inhalant allergens.
    Desvaux, FX
    Inacio, F
    Gayraud, J
    Marrache, F
    Lepage, V
    Loste, MN
    Charron, D
    Peltre, G
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : O862 - O862
  • [47] GENETIC POLYMORPHISMS HLA CLASS II HAPLOTYPES IN HIV INFECTED PATIENTS
    Eglite, Jelena
    Socnevs, Arturs
    Kasjko, Diana
    Viksna, Ludmila
    Sture, Gunta
    TISSUE ANTIGENS, 2012, 79 (06): : 573 - 573
  • [48] Microsatellites in the HLA central region are markers of HLA conserved extended haplotypes
    D'Alfonso, S
    Cappello, N
    Carcassi, C
    Fasano, ME
    Momigliano-Richiardi, P
    HLA - GENETIC DIVERSITY OF HLA FUNCTIONAL AND MEDICAL IMPLICATION, PROCEEDINGS OF THE TWELFTH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE (12TH IHWC), VOL II: CONFERENCE, 1997, : 125 - 127
  • [49] HLA class I and class II antigen frequencies in multiple myeloma
    Alcoceba, M.
    Marin, L. A.
    Balanzategui, A.
    Martin-Jimenez, P.
    Sarasquete, M. E.
    Chillon, C.
    Corral, R.
    Garcia-Sanz, R.
    Gonzalez, M.
    TISSUE ANTIGENS, 2007, 69 (05): : 454 - 454
  • [50] Differential Effect of Bortezomib on HLA Class I and Class II Antibody
    Philogene, Mary Carmelle
    Sikorski, Paul
    Montgomery, Robert A.
    Leffell, Mary S.
    Zachary, Andrea A.
    TRANSPLANTATION, 2014, 98 (06) : 660 - 665